Pinnacle Wealth Planning Services
RXRX icon

Pinnacle Wealth Planning Services’s Recursion Pharmaceuticals RXRX Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$8.24K Buy
+1,994
New +$6.76K ﹤0.01% 2157
2026
Q2 		– Sell
-1,196
Closed -$3.67K – 2819
2026
Q1 		$3.67K Buy
1,196
+1,029
+616% +$3.98K ﹤0.01% 2322
2025
Q4 		$683 Buy
+167
New +$827 ﹤0.01% 2624

Other funds holding RXRX

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Green Alpha Advisors
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
AO
Allen Operations New York $968M AUM 12.84% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Raiffeisen Bank International
Raiffeisen Bank International Vienna, Austria $8.69B AUM 38.11% 1-Year Est. Return
180 Wealth Advisors
180 Wealth Advisors Federal Way, Washington $1.04B AUM 41.44% 1-Year Est. Return
Arizona State Retirement System
Arizona State Retirement System Phoenix, Arizona $20.3B AUM 36.55% 1-Year Est. Return

Pinnacle Wealth Planning Services's RXRX Position: Q3 2026 in Review

Pinnacle Wealth Planning Services opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 1,994 shares worth $8.24K. The stake represents ﹤0.01% of the portfolio and ranks #2157 among its holdings. This is a return to the name: Pinnacle Wealth Planning Services previously reported a position in RXRX as recently as Q1 2026.

Pinnacle Wealth Planning Services first reported a position in RXRX in Q4 2025 and has held it in 3 quarters since. 103 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • Pinnacle Wealth Planning Services held 1,994 shares of Recursion Pharmaceuticals worth $8.24K as of Q3 2026.
  • Recursion Pharmaceuticals was a new Pinnacle Wealth Planning Services position in Q3 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q3 2026, its #2157 holding.
  • Pinnacle Wealth Planning Services first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 103 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q3 2026, filed 27 Oct 2026.